Article info

Download PDFPDF
Extended report
Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab
  1. Correspondence to A Vissink, Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, P O Box 30.001 9700 RB, Groningen, The Netherlands; a.vissink{at}kchir.umcg.nl
View Full Text

Citation

Meiners PM, Arends S, Brouwer E, et al
Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab

Publication history

  • Received July 15, 2011
  • Accepted December 11, 2011
  • First published January 17, 2012.
Online issue publication 
July 14, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.